Abstract
It is essential, in order to minimise expensive drug failures due to toxicity being found in late development or even in clinical trials, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of putative toxicity is advisable even before synthesis. Thus the use of predictive toxicology is called for. A number of in silico approaches to toxicity prediction are discussed. Quantitative structure-activity relationships (QSARs), relating mostly to specific chemical classes, have long been used for this purpose, and exist for a wide range of toxicity endpoints. However, QSARs also exist for the prediction of toxicity of very diverse libraries, although often such QSARs are of the classification type; that is, they predict simply whether or not a compound is toxic, and do not give an indication of the level of toxicity. Examples are given of all of these. A number of expert systems are available for toxicity prediction, most of them covering a range of toxicity endpoints. Those discussed include TOPKAT, CASE, DEREK, HazardExpert, OncoLogic and COMPACT. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled. It is simply amazing that we can formulate any kind of QSAR. The (desired activity) is only the starting point. The truly formidable problem is that of toxicity, especially the difficult long-term toxicities resulting from chronic usage''. (Hansch & Leo [1])
Similar content being viewed by others
References
Hansch, C. and Leo, A., Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, Amer. Chem. Soc., Washington, DC, 1995.
Kennedy, T., Drug Disc. Today, 2 (1997) 436.
Crum Brown, A. and Fraser, T.R., Trans. Roy. Soc. Edinburgh, 25 (1868-69) 151.
Hansch, C., Maloney, P.P., Fujita, T. and Muir, R.M., Nature, 194 (1962) 178.
Hansch, C. and Clayton, J.M., J. Pharm. Sci., 62 (1973) 1.
King, L.A. and Moffat, A.C., Med. Sci. Law, 23 (1983) 193.
Lien, E.J. and Tong, G.L., Cancer Chemother. Rep., 57 1973)
Jarzebski, A., Falkowski, L. and Borowski, E., J. Antibiot. 35 (1982) 220.
Chen, P., Cheng, P.T.W., Alam, M., Beyer, B.D., Bisacchi, G.S., Dejneka, T., Evans, A.J., Greytok, J.A., Hermsmeier, M.A., Humphreys, W.G., Jacobs, G.A., Kocy, O., Lin, P.-F., Lis, K.A., Marella, M.A., Ryono, D.E., Sheaffer, A.K., Spergel, S.H., Sun, C., Tino, J.A., Vite, G., Colonno, R.J., Zahler, R. and Barrish, J.C., J. Med. Chem., 39 (1996) 1991.
Schön, U., Antel, J., Brückner, R. and Messinger, J., Med. Chem., 41 (1998) 318.
Dearden, J.C., Cronin, M.T.D. and Thomas, G.R., J. Pharm. Pharmacol., 51 (1999) Suppl., 267.
Dearden, J.C., Cronin, M.T.D. and Shah, S. J. Pharm. Pharmacol., 51 (1999) Suppl., 266.
Hansch, C., Bjorkroth, J.P. and Leo, A., J. Pharm. Sci., 76 (1987) 663.
Martin, Y.C. and Hansch, C., J. Med. Chem., 14 (1971) 777.
Mannhold, R. and Dross, K., Quant. Struct.-Act. Relat., 15 (1996) 403.
Dearden, J.C., Netzeva, T.I. and Bibby, R., J. Pharm. Pharmacol. 54 (2002) suppl., S–65.
Dearden, J.C., Netzeva, T.I. and Bibby, R., J. Pharm. Pharmacol. 54 (2002) suppl., S–66.
Benigni, R. and Giuliani, A., Med. Res. Rev., 16 (1996) 267.
Dearden, J.C., Cronin, M.T.D., Patel, H. and Raevsky, O.A., J. Pharm. Pharmacol., 52 (2000) Suppl., 221.
Dearden, J.C. and Scott, A.C., J. Pharm. Pharmacol., 54 (2002) Suppl., S–66.
Mumtaz, M.M., Knauf, L.A., Reisman, D.J., Peirano, W.B., Derosa, C.T., Gombar, V.K., Enslein, K., Carter, J.R., Blake, B.W., Huque, K.I. and Ramanujam, V.M.S., Toxicol. Lett., 79 (1995) 131.
Barratt, M.D., ATLA, 23 (1995) 111.
Gao, H., Williams, C.M., Labute, P. and Bajorath, J., J. Chem. Inf. Comput. Sci., 39 (1999) 164.
Dearden, J.C. and Cronin, M.T.D., In Peijnenburg, W.J.G.M. and Damborský, J. (Eds.) Biodegradability Prediction, Kluwer Academic Publishers, Dordrecht, 1996, pp. 93-104.
Dearden, J.C., Barratt, M.D., Benigni, R., Bristol, D.W., Combes, R.D., Cronin, M.T.D., Judson, P.N., Payne, M.P., Richard, A.M., Tichý, M., Worth, A.P. and Yourick, J.J., ATLA, 25 (1997) 223.
Benfenati, E. and Gini, G., Toxicol., 119 (1997) 213.
Richard, A.M., Knowledge Eng. Rev., 14 (1999) 307.
Helma, C., Gottmann, E. and Kramer, S., Stat. Methods Med. Res., 9 (2000) 329.
Greene, N., Adv. Drug Deliv. Rev., 54 (2002) 417.
Enslein, K., Gombar, V.K. and Blake, B.W., Mut. Res., 305 (1994) 47.
Enslein, K., Gombar, V.K., Blake, B.W., Maibach, H.I., Hostynek, J.J., Sigman, C.C. and Bagheri, D., Food Chem. Toxicol., 35 (1997) 1091.
Rosenkranz, H.S., Cunningham, A.R., Zhang, Y.P., Claycamp, H.G., Macina, O.T., Sussman, N.B., Grant, S.G. and Klopman, G., SAR QSAR Environ. Res., 10 (1999) 277.
Cunningham, A.R., Klopman, G. and Rosenkranz, H.S., Mut. Res. - Fund. Mol. Mech. Mut., 405 (1998) 9.
Gomez, J., Macina, O.T., Mattison, D.R., Zhang, Y.P., Klopman, G. and Rosenkranz, H.S., Teratol., 60 (1999) 190.
Matthews, E.J. and Contrera, J.F., Regul. Toxicol. Pharmacol., 28 (1998) 242.
Greene, N., Judson, P.N., Langowski, J.J. and Marchant, C.A., SAR QSAR Environ. Res., 10 (1999) 299.
Steger-Hartmann, T., Yih, T.D., Marchant, C.A. and Langowski, J.J., Naunyn-Schmiedeberg's Arch. Pharmacol., 363 (2001) Suppl., S–363.
Barratt, M.D., Castell, J.V., Miranda, M.A. and Langowski, J.J., J. Photochem. Photobiol. B - Biol., 58 (2000) 54.
Smithing, M.P. and Darvas, F., In Finlay, J.W., Robinson, S.F. and Armstrong, D.J., (Eds.) Food Safety Assessment (American Chemical Society Symposium Series No. 484), American Chemical Society, Washington, DC, 1992, pp. 191-200.
Brown, S.J., Raja, A.A. and Lewis, D.F.V., ATLA, 22 (1994) 482.
Woo, Y.-T., Lai, D., Argus, M. and Arcos, J., Toxicol. Lett., 79 (1995) 219.
Purdy, R., Environ. Health Perspect., 104 (1996) 1085.
Parke, D.V., Ioannides, C. and Lewis, D.F.V., ATLA, 18 (1990) 91.
Lewis, D.F.V., Ioannides, C. and Parke, D.V., Drug Metab. Rev., 30 (1998) 709.
Lewis, D.F.V., J. Chem. Tech. Biotech., 76 (2001) 237.
Lewis, D.F.V., Ioannides, C. and Parke, D.V., Mut. Res., 291 (1993) 61.
Richard, A.M., Mut. Res. - Fund. Mol. Mech. Mutagen., 400 (1998) 493.
Lewis, D.F.V., Bird, M.G. and Jacobs, M.N., Human Exper. Toxicol., 21 (2002) 115.
Benigni, R., Mut. Res. - Environ. Muta., 334 (1995) 103.
Richard, A.M. and Benigni, R., SAR QSAR Environ. Res., 13 (2002) 1.
Benigni, R., Mut. Res. - Rev. Mut. Res., 387 (1997) 35.
Leo, A., Panthananickal, A. and Hansch, C., J. Med. Chem., 24 (1981) 859.
Topliss, J.G. and Costello, R.J., J. Med. Chem., 15 (1972) 1066.
Dunn, W.J. and Wold, S., J. Med. Chem., 21 (1978) 1001.
Rippmann, F., Quant. Struct.-Act. Relat., 9 (1990) 1.
Benigni, R., Giuliani, A., Franke, R. and Gruska, A., Chem. Rev., 100 (2000) 3697.
Benigni, R., Andreoli, C. and Giuliani, A., Carcinogenesis, 10 (1989) 55.
Jurs, P.C., Chou, J.T. and Yuan, M, J. Med. Chem., 22 (1979) 476.
Gini, G., Lorenzini, M., Benfenati, E., Grasso, P. and Bruschi, M., J. Chem. Inf. Comput. Sci., 39 (1999) 1076.
Zhang, L.T., Sannes, K., Shusterman, A.J. and Hansch, C., Chem.-Biol. Interact., 81 (1992) 149.
Blake, B.W., Enslein, K., Gombar, V.K. and Borgstedt, H.H., Mut. Res., 241 (1990) 261.
Moriguchi, I., Hirano, H. and Hirono, S., Environ. Health Perspect., 104 (1996) 1051.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dearden, J.C. In silico prediction of drug toxicity. J Comput Aided Mol Des 17, 119–127 (2003). https://doi.org/10.1023/A:1025361621494
Issue Date:
DOI: https://doi.org/10.1023/A:1025361621494